The identified IL-6/glucose-NK cell axis may explain the exacerbated severity of COVID-19 in patients with diabetes, where pre-existing metabolic stress (chronic hyperglycemia) and acute viral-induced inflammation create a 'double-hit' scenario on antiviral immunity. This evidence concerns the gene IL6 and diabetes mellitus.